Proton Pump Inhibitors and Myocardial Infarction-Reference-Cited by-同舟云学术

Proton Pump Inhibitors and Myocardial Infarction

Published:2015-10 Issue:4 Volume:149 Page:830-833
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Freedberg Daniel E.,Yang Yu-Xiao,Abrams Julian A.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. IMS Health. Top global products 2014. Available from: www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/Press%20Room/Top_line_data/2014/Top_20_Global_Products_2014.pdf. Accessed July 13, 2015.

2. Proton pump inhibitor usage and the risk of myocardial infarction in the general population;Shah;PLoS One,2015

3. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update;Wedemeyer;Drug Saf,2014

4. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects;Fontana;Circulation,2003

5. Antiplatelet drug interactions with proton pump inhibitors;Scott;Expert Opin Drug Metab Toxicol,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drug-delivery strategies to enhance the pharmacological and toxicological properties of Mefenamic acid;Biomedicine & Pharmacotherapy;2024-06

2. Cardiovascular risk with long-term use of proton pump inhibitors: myth or reality. A review;Consilium Medicum;2024-05-02

3. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors;Chonnam Medical Journal;2023

4. Identification of the Components of Proton Pump Inhibitors and Potassium-Competitive Acid Blocker That Lead to Cardiovascular Events in Working-Age Individuals: A 12-Month Retrospective Cohort Study Using a Large Claims Database;Biological and Pharmaceutical Bulletin;2022-09-01

5. Ketogal Safety Profile in Human Primary Colonic Epithelial Cells and in Mice;Pharmaceuticals;2021-11-11